SequelSEC

SS Innovations International, Inc. SSII

Surgical & Medical Instruments & Apparatus · CIK 0001676163 · Fiscal year ends 1231

Revenue
$52.40M
Fiscal year ended 2026-06-30
Operating income
-$8.48M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$270.11MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$1.35Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue6.4×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity7.1×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Revenue YoY growth105.7%92th
CapEx / revenue8.6%80th
Gross margin46.0%25th
SBC / revenue19.1%73th
FCF margin-52.3%32th
Current ratio1.86x32th
R&D / revenue8.7%36th
Net margin-28.5%46th
Operating margin-19.3%50th

SS Innovations International, Inc. (SSII) reported revenue of $52.40M and net income of -$12.43M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from SS Innovations International, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

SS Innovations International, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$52.40M
Cost of revenue$27.43M
Gross profit$24.97M
Operating income-$8.48M
Net income-$12.43M
Research & development$5.57M
Weighted-average diluted sharesUnavailable
Pretax income-$8.16M
Income tax expense$4.27M
Diluted EPSUnavailable
Selling, general & administrative$17.16M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

SS Innovations International, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$13.65M
Total assets$96.98M
Current assets$71.45M
Total liabilities$43.58M
Current liabilities$31.89M
Total equity incl. NCI$53.40M
Temporary (mezzanine) equityUnavailable
Inventory$18.48M
Accounts receivable$16.99M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$5.27M

Cash flow

SS Innovations International, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$15.53M
Capital expendituresUnavailable
Investing cash flow-$2.68M
Financing cash flow$26.10M
Net change in cashUnavailable
Stock-based compensation$9.44M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$1.28M

Derived

SS Innovations International, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin47.6%
Operating margin-16.2%
FCF marginUnavailable
SBC / revenue18.0%
Current ratio2.24x
Revenue YoY growth56.2%
Net margin-23.7%
R&D / revenue10.6%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SSII in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-10View SEC filing
10-Q · Filed 2025-10-28View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-14View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.